Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo.
Endometriosis, a disease of reproductive age women, is a major cause of infertility, menstrual disorders and pelvic pain. Little is known about its etiopathology, but chronic pelvic inflammation is a common feature in affected women. Beside symptomatic treatment of endometriosis-associated pain, onl...
Main Authors: | Khaled Khoufache, Sylvie Bazin, Karine Girard, Julie Guillemette, Marie-Christine Roy, Jean-Pierre Verreault, Yousef Al-Abed, Warren Foster, Ali Akoum |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3359359?pdf=render |
Similar Items
-
Macrophage migration inhibitory factor is involved in ectopic endometrial tissue growth and peritoneal-endometrial tissue interaction in vivo: a plausible link to endometriosis development.
by: Halima Rakhila, et al.
Published: (2014-01-01) -
The Relationship Between Functional Promoter Variants Of Macrophage Migration Inhibitory Factor And Endometriosis
by: Zahra Chekini, et al.
Published: (2021-01-01) -
Control of the of the final stage of immune-mediated diabetes by ISO-1, an antagonist of macrophage migration inhibitory factor
by: Stojanović Ivana, et al.
Published: (2008-01-01) -
Endometriosis, a disease of the macrophage
by: Annalisa eCapobianco, et al.
Published: (2013-01-01) -
Endometriosis and Cancer: Exploring the Role of Macrophages
by: Daria Artemova, et al.
Published: (2021-05-01)